Female genital tract graft-versus-host disease: Incidence, risk factors and recommendations for management

Bone Marrow Transplantation

Volumn 38, Issue 8, 2006, Pages 567-572

  Zantomio, D ^a   Grigg, A P ^a   MacGregor, L ^a   Panek Hudson, Y ^a   Szer, Jeff ^a   Ayton, R ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Allogeneic stem cell transplantation; Genital; Graft versus host; Intervention

Indexed keywords

ANDROGEN; CYCLOSPORIN; ESTROGEN; ETOPOSIDE; FLUDARABINE; GESTAGEN; GLUCOCORTICOID; HYDROCORTISONE ACETATE; MELPHALAN; METHOTREXATE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GYNECOLOGIC DISEASE; HORMONE SUBSTITUTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PATIENT CARE; PRACTICE GUIDELINE; PREMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEXUAL INTERCOURSE; STEM CELL; SURVIVAL TIME; VAGINA; WHOLE BODY RADIATION;

ADMINISTRATION, TOPICAL; ADULT; BONE MARROW TRANSPLANTATION; DISEASE MANAGEMENT; FEMALE; GENITAL DISEASES, FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33749443093     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705487     Document Type: Article

References (11)

1. Spinelli S, Chiodi S, Costantini S, Van Lint MT, Raiola AM, Ravera GB et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica 2003; 88: 1163-1168.
2. Yanai N, Shufaro Y, Or R, Meirow D. Vaginal outflow tract obstruction by graft-versus-host reaction. Bone Marrow Transplant 1999; 24: 811-812.
3. DeLord C, Treleaven J, Shepherd J, Saso R, Powles RL. Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant 1999; 23: 523-525.
4. Couriel D, Carpenter PA, Cutler C, Bolanos-Meade J, Treister NS, Gea-Banacloche J et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12: 375-396.
5. Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: A prospective randomized study. Blood 2000; 96: 2391-2398.
6. Lobashevsky AL, Senkbeil RW, Townsend JE, Mink CA, Thomas JM. Quantitative analysis of chimerism using a short tandem repeat method on a fluorescent automated DNA sequencer. Clin Lab Haematol 2006; 28: 40-49.
7. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827-838.
8. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215-233.
9. Schmitz N, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E et al. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. Haematologica 2005; 90: 643-648.
10. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: Long-term follow-up of a randomized trial. Blood 2002; 100: 415-419.
11. Spiryda LB, Laufer MR, Soiffer RJ, Antin JA. Graft-versus-host disease of the vulva and/or vagina: Diagnosis and treatment. Biol Blood Marrow Transplant 2003; 9: 760-765.